Literature DB >> 9169788

Efficient immunity against Leishmania major in the absence of interleukin-6.

N H Moskowitz1, D R Brown, S L Reiner.   

Abstract

Mice genetically deficient in the pleiotropic cytokine interleukin-6 (IL-6) exhibit immunodeficiency against viral, bacterial, and fungal pathogens. When challenged with the protozoan parasite Leishmania major, IL-6-deficient mice controlled infection and mounted strong Th1 responses as efficiently as IL-6-sufficient littermates. Thus, the successful activation of parasitized macrophages and class II-restricted T cells does not require a full inflammatory repertoire.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169788      PMCID: PMC175340          DOI: 10.1128/iai.65.6.2448-2450.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Constructing polycompetitor cDNAs for quantitative PCR.

Authors:  S L Reiner; S Zheng; D B Corry; R M Locksley
Journal:  J Immunol Methods       Date:  1993-09-27       Impact factor: 2.303

2.  Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.

Authors:  L Q Vieira; M Goldschmidt; M Nashleanas; K Pfeffer; T Mak; P Scott
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

3.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis.

Authors:  Z E Wang; S L Reiner; F Hatam; F P Heinzel; J Bouvier; C W Turck; R M Locksley
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

5.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.

Authors:  T M Scharton; P Scott
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

6.  Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice.

Authors:  R M Locksley; S L Reiner; F Hatam; D R Littman; N Killeen
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

7.  Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.

Authors:  J Rothe; W Lesslauer; H Lötscher; Y Lang; P Koebel; F Köntgen; A Althage; R Zinkernagel; M Steinmetz; H Bluethmann
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

8.  IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.

Authors:  D E Hatzigeorgiou; S He; J Sobel; K H Grabstein; A Hafner; J L Ho
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

9.  Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

Authors:  C S Tripp; S F Wolf; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody.

Authors:  J W Conlan; R J North
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  16 in total

1.  Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.

Authors:  I K Santos; C H Costa; H Krieger; M F Feitosa; D Zurakowski; B Fardin; R B Gomes; D L Weiner; D A Harn; R A Ezekowitz; J E Epstein
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Protective immunity to rotavirus shedding in the absence of interleukin-6: Th1 cells and immunoglobulin A develop normally.

Authors:  J L VanCott; M A Franco; H B Greenberg; S Sabbaj; B Tang; R Murray; J R McGhee
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection.

Authors:  B M Saunders; A A Frank; I M Orme; A M Cooper
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 5.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

6.  Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.

Authors:  R G Titus; G K DeKrey; R V Morris; M B Soares
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

7.  Keratinocytes determine Th1 immunity during early experimental leishmaniasis.

Authors:  Jan M Ehrchen; Kirsten Roebrock; Dirk Foell; Nadine Nippe; Esther von Stebut; Johannes M Weiss; Niels-Arne Münck; Dorothee Viemann; Georg Varga; Carsten Müller-Tidow; Hans-Joachim Schuberth; Johannes Roth; Cord Sunderkötter
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

8.  The IL-6-deficient mouse exhibits impaired lymphocytic responses to a vaccine combining live Leishmania major and CpG oligodeoxynucleotides.

Authors:  Wenhui Wu; Luise Weigand; Susana Mendez
Journal:  Can J Microbiol       Date:  2009-06       Impact factor: 2.419

9.  Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice.

Authors:  Carole Dumas; Anthony Muyombwe; Gaétan Roy; Claudine Matte; Marc Ouellette; Martin Olivier; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.

Authors:  Henry W Murray
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.